The Next Generation of Artificial
 Intelligence is…

Synthetic Intelligence…

Synthetic Intelligence, Inc.
Artificial Intelligence
        Platform
Best of breed
World class
Proprietary algorithms
First Application
 Outsourcing automation of key
 assessment & selection
 services–
Next generation “Offshoring”
Pain
 Knowledge Workers are expensive
 Trend has been to “offshore” everything
 from software development to
 telephone based customer service

But this offers only an incremental cost
 improvement…
Solution
With Synthetic Intelligence, SI replaces
the human with not just a machine, but
a “synthetic human” intelligence
This offers an order of magnitude
improvement in
 cost
 speed
 and accuracy
Initial Markets/Roll-out
    3 Phase market vertical roll-out

   1st Market Vertical– legal industry
   2nd Market Vertical– recruiting industry

   3rd Market Vertical– VC industry
Case Study
    Venture Capital-- Implementing SI
    achieved the following:
   Shortened time to decision by 10,000%
   Order of magnitude reduction of # of general
    partners required for $1B fund
   Probability of success increased from 1 in 10 to 2 in
    10, a 100% increase

    Same math can be applied to the legal and
    recruiting community…
Underlying Technology
Combination of best of breed in
 Neural networks
 Artificial intelligence

 Genetic algorithm
2nd Application
Biotechnology drug discovery
  Pain: hard to discover/validate drug
  targets using conventional methods
  Solution: SI solves this by making
  decisions on which targets to run with in
  all three stages of product
  development, pre-clinical & clinical drug
  development
The Product
Biotech drug discovery
 Based on same platform technology
 Targets will be identified

 Once match is made, will file IND

 Then go to clinical trials in less than 6
  months
Current IND Product Candidates
   C3PO
C3PO is a bi-specific monoclonal antibody targeting a tumor specific
antigen (Galactica) which is over-expressed on adenocarcinomas such as
pancreatic, ovarian and colon cancers.

C3PO is constructed of a proprietary linker joining two antibodies; one
binding to the R2D2 receptor on immune T cells (cytolytic effector) and the
other to Galactica on cancer cells.

Once bound to Galactica on the cancer cells, the proprietary linker facilitates
the killing of primary and metastasized tumor cells by the T cell

C3PO has been shown to be effective in vivo in reducing growth in
colorectal tumors with specificity to those tumors with Galactica positive
antigens
Team
CEO– “X” (will disclose name upon
funding) currently leader of Fortune 10
company, willing to leave the role for
this start-up once we receive funding
VP Sales– “Y”, 30 years of sales
experience, very good.
Rest of Org Chart-- TBD
Strategic Advisory
Vince Fulmer Board
   MIT Enterprise Forum Chair Emeritus
        entrepreneurial expert
        author of the phrase, “We are students and practitioners
         of entrepreneurship. We are specialists in promoting the
         field of technology entrepreneurship”
        Weekend warrior and winner of MIT EF body builder
         Competition, 2004
Trish Fleming
   Executive Director, MIT Enterprise Forum
        Glad-handing networker extraordinaire
        Fashion Diva, and E! Entertainment fashion
         commentator replacement for Joan Rivers
SI Revenue Projections



                                     2004         %            2005           %            2006          %            2007        %

  Gross Sales                    $   2,860,500   100.00%   $   12,763,750    100.00%   $   29,293,500   100.00%   $ 56,118,500   100.00%
  Cost/ Goods Sold (COGS)              679,050    23.74%        1,821,150     14.27%        2,898,450     9.89%      3,214,350     5.73%
  Gross Profit                   $   2,181,450    76.26%   $   10,942,600     85.73%   $   26,395,050    90.11%   $ 52,904,150    94.27%

  Operating Expenses
  Salary (Office & Overhead)     $     563,000   19.68%    $    1,099,000     8.61%    $    1,647,000    5.62%    $  1,839,000    3.28%
  Payroll (taxes etc.)                 197,050    6.89%           384,650     3.01%           576,450    1.97%         643,650    1.15%
  Outside Services                      34,000    1.19%           300,000     2.35%           750,000    2.56%         350,000    0.62%
  Supplies (off and operation)          17,000    0.59%           150,000     1.18%           400,000    1.37%         600,000    1.07%
  Repairs/ Maintenance                  11,000    0.38%            70,000     0.55%           100,000    0.34%         300,000    0.53%
  Advertising                           31,000    1.08%           100,000     0.78%           150,000    0.51%         200,000    0.36%
  Car, Delivery and Travel              50,000    1.75%           100,000     0.78%           200,000    0.68%         400,000    0.71%
  Accounting and Legal                  46,000    1.61%           100,000     0.78%           100,000    0.34%         250,000    0.45%
  Rent                                  70,000    2.45%           300,000     2.35%           300,000    1.02%         300,000    0.53%
  Telephone                             14,750    0.52%            10,000     0.08%            50,000    0.17%         100,000    0.18%
  Utilities                             12,700    0.44%            30,000     0.24%            40,000    0.14%          60,000    0.11%
  Insurance                             57,500    2.01%           100,000     0.78%           200,000    0.68%         250,000    0.45%
  Misc. & Contingency                   37,000    1.29%           200,000     1.57%           200,000    0.68%         300,000    0.53%
  Investor Exit Option                       -    0.00%          3,575,000   28.01%                 -    0.00%               -    0.00%
  Acquisition(s)                             -    0.00%                  -    0.00%                 -    0.00%               -    0.00%
  Eqpt Lease & Netw / Com              135,000    4.72%           250,000     1.96%           250,000    0.85%         750,000    1.34%
  (Com Pool + Reserve) (15%)           429,075   15.00%         1,914,563    15.00%         4,394,025   15.00%       8,417,775   15.00%
  Total Expenses                 $   1,705,075   59.61%    $    8,683,213    68.03%    $    9,357,475   31.94%    $ 14,760,425   26.30%

  Net Profit Before Tax                476,375                  2,259,388                  17,037,575               38,143,725
  Income Taxes                         157,204                    745,598                   5,622,400               12,587,429
  Net Profit After Tax                 319,171                  1,513,790                  11,415,175               25,556,296
  Owner Draw/ Dividends                250,000                    500,000                   5,000,000               15,000,000
  Adj. to Retained Earnings      $      69,171                 $1,013,790              $    6,415,175             $ 10,556,296
Funding
Currently seeking 15M
   Use of funds
      Accrued wages (particularly founders)
      Infrastructure (office space, furniture, telecom)
            US
            Europe
            Asia
            Bali
Funding    (continued)

Funding Alternatives
2.5M
    Accrued   wages (particularly founders)
    Infrastructure (office space, furniture, telecom)
       US
       Bali


   Or, $250,000
     Accrued   wages (1 founder)
     Infrastructure (office space, furniture, telecom)
              Bali
Exit


 Lifestyle business
 If necessary, conversion to 501C3
 “.org”

Contact: beachbum@bali.org

Synthetic Intelligence (2004)

  • 1.
    The Next Generationof Artificial Intelligence is… Synthetic Intelligence… Synthetic Intelligence, Inc.
  • 2.
    Artificial Intelligence Platform Best of breed World class Proprietary algorithms
  • 3.
    First Application Outsourcingautomation of key assessment & selection services– Next generation “Offshoring”
  • 4.
    Pain Knowledge Workersare expensive Trend has been to “offshore” everything from software development to telephone based customer service But this offers only an incremental cost improvement…
  • 5.
    Solution With Synthetic Intelligence,SI replaces the human with not just a machine, but a “synthetic human” intelligence This offers an order of magnitude improvement in  cost  speed  and accuracy
  • 6.
    Initial Markets/Roll-out 3 Phase market vertical roll-out  1st Market Vertical– legal industry  2nd Market Vertical– recruiting industry  3rd Market Vertical– VC industry
  • 7.
    Case Study Venture Capital-- Implementing SI achieved the following:  Shortened time to decision by 10,000%  Order of magnitude reduction of # of general partners required for $1B fund  Probability of success increased from 1 in 10 to 2 in 10, a 100% increase Same math can be applied to the legal and recruiting community…
  • 8.
    Underlying Technology Combination ofbest of breed in  Neural networks  Artificial intelligence  Genetic algorithm
  • 9.
    2nd Application Biotechnology drugdiscovery Pain: hard to discover/validate drug targets using conventional methods Solution: SI solves this by making decisions on which targets to run with in all three stages of product development, pre-clinical & clinical drug development
  • 10.
    The Product Biotech drugdiscovery  Based on same platform technology  Targets will be identified  Once match is made, will file IND  Then go to clinical trials in less than 6 months
  • 11.
    Current IND ProductCandidates C3PO C3PO is a bi-specific monoclonal antibody targeting a tumor specific antigen (Galactica) which is over-expressed on adenocarcinomas such as pancreatic, ovarian and colon cancers. C3PO is constructed of a proprietary linker joining two antibodies; one binding to the R2D2 receptor on immune T cells (cytolytic effector) and the other to Galactica on cancer cells. Once bound to Galactica on the cancer cells, the proprietary linker facilitates the killing of primary and metastasized tumor cells by the T cell C3PO has been shown to be effective in vivo in reducing growth in colorectal tumors with specificity to those tumors with Galactica positive antigens
  • 12.
    Team CEO– “X” (willdisclose name upon funding) currently leader of Fortune 10 company, willing to leave the role for this start-up once we receive funding VP Sales– “Y”, 30 years of sales experience, very good. Rest of Org Chart-- TBD
  • 13.
    Strategic Advisory Vince FulmerBoard  MIT Enterprise Forum Chair Emeritus  entrepreneurial expert  author of the phrase, “We are students and practitioners of entrepreneurship. We are specialists in promoting the field of technology entrepreneurship”  Weekend warrior and winner of MIT EF body builder Competition, 2004 Trish Fleming  Executive Director, MIT Enterprise Forum  Glad-handing networker extraordinaire  Fashion Diva, and E! Entertainment fashion commentator replacement for Joan Rivers
  • 14.
    SI Revenue Projections 2004 % 2005 % 2006 % 2007 % Gross Sales $ 2,860,500 100.00% $ 12,763,750 100.00% $ 29,293,500 100.00% $ 56,118,500 100.00% Cost/ Goods Sold (COGS) 679,050 23.74% 1,821,150 14.27% 2,898,450 9.89% 3,214,350 5.73% Gross Profit $ 2,181,450 76.26% $ 10,942,600 85.73% $ 26,395,050 90.11% $ 52,904,150 94.27% Operating Expenses Salary (Office & Overhead) $ 563,000 19.68% $ 1,099,000 8.61% $ 1,647,000 5.62% $ 1,839,000 3.28% Payroll (taxes etc.) 197,050 6.89% 384,650 3.01% 576,450 1.97% 643,650 1.15% Outside Services 34,000 1.19% 300,000 2.35% 750,000 2.56% 350,000 0.62% Supplies (off and operation) 17,000 0.59% 150,000 1.18% 400,000 1.37% 600,000 1.07% Repairs/ Maintenance 11,000 0.38% 70,000 0.55% 100,000 0.34% 300,000 0.53% Advertising 31,000 1.08% 100,000 0.78% 150,000 0.51% 200,000 0.36% Car, Delivery and Travel 50,000 1.75% 100,000 0.78% 200,000 0.68% 400,000 0.71% Accounting and Legal 46,000 1.61% 100,000 0.78% 100,000 0.34% 250,000 0.45% Rent 70,000 2.45% 300,000 2.35% 300,000 1.02% 300,000 0.53% Telephone 14,750 0.52% 10,000 0.08% 50,000 0.17% 100,000 0.18% Utilities 12,700 0.44% 30,000 0.24% 40,000 0.14% 60,000 0.11% Insurance 57,500 2.01% 100,000 0.78% 200,000 0.68% 250,000 0.45% Misc. & Contingency 37,000 1.29% 200,000 1.57% 200,000 0.68% 300,000 0.53% Investor Exit Option - 0.00% 3,575,000 28.01% - 0.00% - 0.00% Acquisition(s) - 0.00% - 0.00% - 0.00% - 0.00% Eqpt Lease & Netw / Com 135,000 4.72% 250,000 1.96% 250,000 0.85% 750,000 1.34% (Com Pool + Reserve) (15%) 429,075 15.00% 1,914,563 15.00% 4,394,025 15.00% 8,417,775 15.00% Total Expenses $ 1,705,075 59.61% $ 8,683,213 68.03% $ 9,357,475 31.94% $ 14,760,425 26.30% Net Profit Before Tax 476,375 2,259,388 17,037,575 38,143,725 Income Taxes 157,204 745,598 5,622,400 12,587,429 Net Profit After Tax 319,171 1,513,790 11,415,175 25,556,296 Owner Draw/ Dividends 250,000 500,000 5,000,000 15,000,000 Adj. to Retained Earnings $ 69,171 $1,013,790 $ 6,415,175 $ 10,556,296
  • 15.
    Funding Currently seeking 15M  Use of funds  Accrued wages (particularly founders)  Infrastructure (office space, furniture, telecom)  US  Europe  Asia  Bali
  • 16.
    Funding (continued) Funding Alternatives 2.5M Accrued wages (particularly founders) Infrastructure (office space, furniture, telecom) US Bali  Or, $250,000 Accrued wages (1 founder) Infrastructure (office space, furniture, telecom)  Bali
  • 17.
    Exit Lifestyle business If necessary, conversion to 501C3 “.org” Contact: beachbum@bali.org